The role of remote monitoring in detecting of the defibrillation lead dislocation: case report
https://doi.org/10.29001/2073-8552-2023-38-2-235-240
Abstract
Remote monitoring systems of implanted antiarrhythmic devices are becoming a common method of functioning monitoring with the possibility of recording arrhythmias and transmitting data to a doctor, along with routine checks in medical institutions. It is important to inform patients about possible unscheduled visits to the hospital if necessary and to be in touch with them. In the clinical case presented below, the patient did not feel the shock discharge of the implanted cardioverter-defibrillator and did not contact the clinic. The alarm notification received by the doctor and the subsequent analysis of the remote monitoring data made it possible to identify and promptly eliminate the dislocation of the defibrillation lead in a hospital.
About the Authors
A. Yu. Amiraslanov
The National Medical Research Center of Surgery named after A. Vishnevsky
Russian Federation
Russian Federation
Anar Yu. Amiraslanov - Cand. Sci. (Med.), Cardiovascular Surgeon
27, Bolshaya Serpuhovskaya str., Moscow, 115093, Russian Federation
E. V. Dedukh
The National Medical Research Center of Surgery named after A. Vishnevsky
Russian Federation
Russian Federation
Elizaveta V. Dedukh - Junior Research Scientist
27, Bolshaya Serpuhovskaya str., Moscow, 115093, Russian Federation
E. A. Artyukhina
The National Medical Research Center of Surgery named after A. Vishnevsky
Russian Federation
Russian Federation
Elena A. Artyukhina - Dr. Sci. (Med.), Head of the Department of Electrophysiological X-Ray Endovascular Methods for Diagnosis and Treatment of Arrhythmias
27, Bolshaya Serpuhovskaya str., Moscow, 115093, Russian Federation
References
1. Van Dijk V.F., Boersma L.V. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond. Trends Cardiovasc. Med. 2020;30(6):378–384. DOI: 10.1016/j.tcm.2019.09.006.
2. Glikson M., Nielsen C., Kronborg M., Michowitz Y., Auricchio A., Barbash I.M. et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 2021;42(35):3427–3520. DOI:10.1093/eurheartj/ehab364.
3. Lebedeva V.K., Lyubimtseva T.A., Lebedev D.S. Remote monitoring in management of patients with cardiac pacemakers, implantable cardioverters-defibrillators, and devices for cardiac resynchronization therapy.Journal of Arrhythmology. 2017;(88):57–61. (In Russ.).
4. Burri H., Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace. 2009;11(6):701–709. DOI: 10.1093/europace/eup110.
5. Health Quality Ontario. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment. Ont. Health Technol. Assess Ser. 2018;18(7):1–199.
6. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin. Electrophysiol. 2007;30(s1):S2–S12. DOI: 10.1111/j.1540-8159.2007.00595.x.
7. Spencker S., Coban N., Koch L., Schirdewan A., Müller D. et al. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):483–488. DOI: 10.1093/europace/eun350.
8. Varma N., Epstein A.E., Irimpen A., Schweikert R., Love C. et al. TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122(4):325–332. DOI: 10.1161/CIRCULATIONAHA.110.937409.
9. Mabo P., Victor F., Bazin P., Ahres S., Babuty D., Da Costa A. et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur. Heart J. 2012;33(9):1105–1111. DOI: 10.1093/eurheartj/ehr419.
10. Costa R., Silva K.R.D., Saucedo S.C.M., Silva L.A., Crevelari E.S., Nascimento W.T.J. et al. Impact of the COVID-19 Pandemic on сardiac implantable electronic devices procedures in a Tertiary Referral Center. Arq. Bras. Cardiol. 2021;117(4):765–769. DOI: 10.36660/abc.20201378.
11. Maines M., Zorzi A., Benetollo P.P., Guarrera G.M., Moz M., Manica A. et al. Short-term outcome associated with remote evaluation (telecardiology) of patients with cardiovascular diseases during the COVID-19 pandemic. Int. J. Cardiol. Heart Vasc. 2020;30:100625. DOI: 10.1016/j.ijcha.2020.100625.
12. Trunova O.S., Durmanov S.S., Bazylev V.V. Influence of remote monitoring of implantable cardioverter-defibrillator on the quality of life of patients. Journal of Arrhythmology. 2019;26(1):17–23. (In Russ.). DOI:10.25760/VA-2019-95-17-23.
13. Damrina E.V., Ilov N.N. Follow-up of patients with ICD: In-clinic interrogating or remote monitoring? The Siberian Journal of Clinical and Experimental Medicine. 2017;32(1):84–87. (In Russ.). DOI: 10.29001/2073-8552-2017-32-1-84-87.
14. Ricci R., Morichelli L., Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace. 2009;11(1):54–61. DOI: 10.1093/europace/eun303.
15. Zaman J.A.B., Chua K., Sovari A.A., Gunderson B., Gang E.S., Ploux S.et al. Early diagnosis of defibrillation lead dislodgement. JACC Clin. Electrophysiol. 2018;4(8):1075–1088. DOI: 10.1016/j.jacep.2018.03.015.
Review
For citations:
Amiraslanov A.Yu., Dedukh E.V., Artyukhina E.A. The role of remote monitoring in detecting of the defibrillation lead dislocation: case report. Siberian Journal of Clinical and Experimental Medicine. 2023;38(2):235-240. (In Russ.) https://doi.org/10.29001/2073-8552-2023-38-2-235-240
Views:
326
.png)
Email this article 